Abstract
Cocaine dependence continues to be a highly prevalent disorder, which is associated with significant morbidity and mortality. Numerous medications have been investigated as potential adjunctive therapeutic measures, but with minimal success. None have been given Food and Drug Administration approval for treatment of cocaine dependence. (Am J Addict 2011;00:1-2).
© American Academy of Addiction Psychiatry.
Publication types
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Behavior, Addictive / drug therapy*
-
Citalopram / adverse effects
-
Citalopram / therapeutic use*
-
Cocaine-Related Disorders / drug therapy*
-
Cocaine-Related Disorders / prevention & control
-
Cocaine-Related Disorders / psychology
-
Humans
-
Male
-
Patient Compliance / statistics & numerical data
-
Pilot Projects
-
Secondary Prevention
-
Selective Serotonin Reuptake Inhibitors / adverse effects
-
Selective Serotonin Reuptake Inhibitors / therapeutic use*
-
Veterans / psychology*
Substances
-
Serotonin Uptake Inhibitors
-
Citalopram